Targeting Metabolism: Innovative Therapies for MASLD Unveiled
International Journal of Molecular Sciences · 25.04.2025 · 26 (9) · 4077
DOI: 10.3390/ijms26094077 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.04.2025. Verfasst von Weixin Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Fatty Liver, Metabolic Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 401 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Provincial Scientific and Technological Development Program, Jilin Provincial Scientific and Technological Development.
Abstract (Originalsprache)
The recent introduction of the term metabolic-dysfunction-associated steatotic liver disease (MASLD) has highlighted the critical role of metabolism in the disease’s pathophysiology. This innovative nomenclature signifies a shift from the previous designation of non-alcoholic fatty liver disease (NAFLD), emphasizing the condition’s progressive nature. Simultaneously, MASLD has become one of the most prevalent liver diseases worldwide, highlighting the urgent need for research to elucidate its etiology and develop effective treatment strategies. This review examines and delineates the revised definition of MASLD, exploring its epidemiology and the pathological changes occurring at various stages of the disease. Additionally, it identifies metabolically relevant targets within MASLD and provides a summary of the latest metabolically targeted drugs under development, including those in clinical and some preclinical stages. The review finishes with a look ahead to the future of targeted therapy for MASLD, with the goal of summarizing and providing fresh ideas and insights.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
- School of Public Health, Jilin University, Changchun 130021, China.
- NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun 130041, China.
ORCID-Profile: Jinping Yin, Kan He
Förderung
- Jilin Provincial Scientific and Technological Development Program
- Jilin Provincial Scientific and Technological Development
Zitieren
APA
Wang, W., Gao, X., Niu, W., Yin, J., & He, K. (2025). Targeting Metabolism: Innovative Therapies for MASLD Unveiled. International Journal of Molecular Sciences, 26(9), 4077. https://doi.org/10.3390/ijms26094077
Vancouver
Wang W, Gao X, Niu W, Yin J, He K. Targeting Metabolism: Innovative Therapies for MASLD Unveiled. International Journal of Molecular Sciences. 2025;26(9):4077. doi:10.3390/ijms26094077
BibTeX
@article{Wang2025,
author = {Wang, Weixin and Gao, Xin and Niu, Wentong and Yin, Jinping and He, Kan},
title = {Targeting Metabolism: Innovative Therapies for MASLD Unveiled},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {9},
pages = {4077},
doi = {10.3390/ijms26094077}
}
EUVIMED